The RSI Indicator for BCYC moved out of oversold territory on October 05, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 48 similar instances when the indicator left oversold territory. In 40 of the 48 cases the stock moved higher. This puts the odds of a move higher at 83%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on BCYC as a result. In 60 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for BCYC just turned positive on October 22, 2026. Looking at past instances where BCYC's MACD turned positive, the stock continued to rise in 36 of 46 cases over the following month. The odds of a continued upward trend are 78%.
Following a +6.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where BCYC advanced for three days, in 188 of 247 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 48 cases where BCYC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
BCYC moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BCYC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
BCYC broke above its upper Bollinger Band on October 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BCYC entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 28 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.497) is normal, around the industry mean (3.162). P/E Ratio (-1.326) is within average values for comparable stocks, (-1.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.622) among similar stocks. P/S Ratio (4.136) is also within normal values, averaging (439.647).
The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. BCYC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BCYC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The RSI Oscillator for NRXP moved into overbought territory on October 30, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Moving Average Convergence Divergence (MACD) for NRXP just turned positive on October 27, 2026. Looking at past instances where NRXP's MACD turned positive, the stock continued to rise in 33 of 39 cases over the following month. The odds of a continued upward trend are 85%.
Following a +8.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where NRXP advanced for three days, in 191 of 233 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
NRXP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 42 cases where NRXP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 86%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NRXP as a result. In 70 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NRXP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for NRXP entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: NRXP's P/B Ratio (-552.658) is very low in comparison to the industry average of (3.162). P/E Ratio (-4.255) is within average values for comparable stocks, (-1.064). Projected Growth (PEG Ratio) (0.220) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.622) among similar stocks. P/S Ratio (29.851) is also within normal values, averaging (439.647).
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. NRXP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NRXP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
BCYC | NRXP | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 36 Fair valued | 1 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 97 | 100 | |
PRICE GROWTH RATING 1..100 | 73 | 80 | |
P/E GROWTH RATING 1..100 | 28 | 11 | |
SEASONALITY SCORE 1..100 | n/a | 14 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NRXP's Valuation (1) in the null industry is somewhat better than the same rating for BCYC (36). This means that NRXP’s stock grew somewhat faster than BCYC’s over the last 12 months.
NRXP's Profit vs Risk Rating (100) in the null industry is in the same range as BCYC (100). This means that NRXP’s stock grew similarly to BCYC’s over the last 12 months.
BCYC's SMR Rating (97) in the null industry is in the same range as NRXP (100). This means that BCYC’s stock grew similarly to NRXP’s over the last 12 months.
BCYC's Price Growth Rating (73) in the null industry is in the same range as NRXP (80). This means that BCYC’s stock grew similarly to NRXP’s over the last 12 months.
NRXP's P/E Growth Rating (11) in the null industry is in the same range as BCYC (28). This means that NRXP’s stock grew similarly to BCYC’s over the last 12 months.
| BCYC | NRXP | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 83% | 4 days ago 85% |
| Stochastic ODDS (%) | 4 days ago 90% | 4 days ago 86% |
| Momentum ODDS (%) | 4 days ago 72% | 4 days ago 86% |
| MACD ODDS (%) | 4 days ago 78% | 4 days ago 85% |
| TrendWeek ODDS (%) | 4 days ago 73% | 4 days ago 88% |
| TrendMonth ODDS (%) | 4 days ago 87% | 4 days ago 90% |
| Advances ODDS (%) | 6 days ago 76% | 7 days ago 82% |
| Declines ODDS (%) | 4 days ago 89% | 4 days ago 89% |
| BollingerBands ODDS (%) | 4 days ago 84% | 4 days ago 77% |
| Aroon ODDS (%) | 4 days ago 84% | 4 days ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BCYC’s FA Score shows that 1 FA rating(s) are green while NRXP’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BCYC’s TA Score shows that 4 TA indicator(s) are bullish while NRXP’s TA Score has 4 bullish TA indicator(s).
BCYC (@Biotechnology) experienced а +3.10% price change this week, while NRXP (@Biotechnology) price change was -8.84% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -13.09%, and the average quarterly price growth was -20.02%.
BCYC is expected to report earnings on Mar 02, 2027.
NRXP is expected to report earnings on Nov 13, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PCVX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PCVX could also see price increases.
| Ticker / NAME | Correlation To BCYC | 1D Price Change % | ||
|---|---|---|---|---|
| BCYC | 100% | -4.19% | ||
| PCVX - BCYC | 57% Loosely correlated | -0.93% | ||
| ARCT - BCYC | 50% Loosely correlated | -9.22% | ||
| EDIT - BCYC | 49% Loosely correlated | -8.87% | ||
| RCKT - BCYC | 49% Loosely correlated | -3.94% | ||
| VIR - BCYC | 47% Loosely correlated | -3.83% | ||
More | ||||
A.I.dvisor indicates that over the last year, NRXP has been closely correlated with TAOX. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then TAOX could also see price increases.
| Ticker / NAME | Correlation To NRXP | 1D Price Change % | ||
|---|---|---|---|---|
| NRXP | 100% | -14.66% | ||
| TAOX - NRXP | 84% Closely correlated | -10.44% | ||
| ALLR - NRXP | 81% Closely correlated | -2.20% | ||
| PALI - NRXP | 74% Closely correlated | -2.52% | ||
| COYA - NRXP | 38% Loosely correlated | -9.30% | ||
| BCYC - NRXP | 33% Loosely correlated | -4.19% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| HERZ | 15.25 | N/A | N/A |
| Herzfeld Credit Income Fund Inc. | |||
| RKSG | 28.99 | N/A | N/A |
| Ruk Strategic Growth ETF (RKSG) | |||
| NUHY | 20.42 | -0.06 | -0.27% |
| Nuveen ESG High Yield Corporate Bond ETF (NUHY) | |||
| ZHDG | 23.63 | -0.45 | -1.85% |
| Zega Buy & Hedge ETF (ZHDG) | |||
| QQEW | 151.32 | -5.11 | -3.26% |
| First Trust Nasdaq-100 Select Equal Weight ETF (QQEW) | |||